Navigation Links
USDM Life Sciences Announces New Solution for Continuous GxP Compliance on Microsoft
Date:7/22/2020

USDM Life Sciences, a premier consulting firm driving digital transformation and innovation in technology and compliance, announces a new solution to manage regulated workloads on Microsoft Azure.

Regulated biotechnology, pharmaceutical, and medical device companies must ensure every layer of their technology stack complies with FDA and global regulations. USDM's new managed service for regulated workloads in the public cloud covers end-to-end technology and compliance solutions to addresses business applications, cloud services, and global infrastructure. With Unify Public Cloud, Microsoft customers will get access to unmatched compliance services, fast-start accelerators, and defensible validation deliverables based on twenty years of regulatory domain expertise and technology solution implementation.

"Now, more than ever, life science companies are prioritizing their business transformation through cloud technologies to not only maintain business continuity but accelerate their high-impact growth outcomes," said Kevin Brown, CEO of USDM Life Sciences. "By providing a total, continuous, GxP compliant solution for regulated workloads, USDM can help minimize regulatory risk and maximize innovation for our customers creating vital drugs, therapies, and medical devices."

USDM's cost-effective, prepackaged, Unify Public Cloud solution speeds up the deployment and adoption of Azure, minimizes compliance risk, and realizes business value faster by leveraging decades of life sciences expertise.

"At Microsoft, we're focused on continually developing new ways to empower our customers to increase productivity and improve business outcomes," said Patty Obermaier, Vice President, U.S. Health & Life Sciences at Microsoft Corp. "USDM, delivers accelerated GxP solutions that enable continuous cloud compliance to help reduce regulatory burdens."

Unify Public Cloud for Azure addresses and meets a growing, critical demand for life science companies to enable complete digital business processes and efficiently manage GxP compliance requirements.

Learn More

Please join us for a webinar discussing how you can move your regulated GxP workload to Microsoft Azure.

Thursday, July 30th, 2:00 PM - 3:00 PM EDT

Register Here

Availability

Unify Public Cloud for Azure is available for all Microsoft life sciences customers on the Azure Marketplace. To learn how you can migrate your regulated workload to Azure, contact USDM at usdm@usdm.com.

About USDM Life Sciences

USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM Life Sciences focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world's top technology software developers. For more information, visit http://www.usdm.com.

Read the full story at https://www.prweb.com/releases/usdm_life_sciences_announces_new_solution_for_continuous_gxp_compliance_on_microsoft/prweb17267952.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. DuPont Nutrition & Biosciences Unveils Brewing Liquefaction Enzyme Solution AMYLEX® 6T
2. DuPont Nutrition & Biosciences Launches Bonlacta™ Dairy Enzyme in North America for Lactose-Free Market
3. Flagship Biosciences and Corritori Consulting Announce Strategic Alliance - Companies Now Delivering Regulatory Services to the Pharmaceutical Industry
4. Box, ComplianceQuest and USDM Life Sciences Partner to Launch Unify Compliance Cloud
5. Flagship Biosciences Hires New Vice President of Clinical Diagnostics
6. OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project
7. Jason Burke Joins CREO, Inc. as Partner to Head Analytics and Data Sciences Practice
8. INDIGO Biosciences Announces Record Revenue Numbers for 2019
9. New Investments Boost Colorado’s Life Sciences Community
10. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
11. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
(Date:6/23/2020)... MILTON KEYNES, England (PRWEB) , ... June 23, ... ... operations in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and ... rapid response project to support testing operations in the fight against the COVID-19 ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been ... webinar will cover the history of eSource, the reasons it did not take off ... wearables, to site source, the industry is moving towards capturing data electronically for clinical ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , ... and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting ... utilize existing data in order to identify and prioritize patients for care. , ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
Breaking Biology Technology: